VASH2 was expressed in human endometrial cancer cell lines, and the specific knockdown of VASH2 from the endometrial cancer cell line, HEC50B, significantly inhibited tumor growth by decreasing tumor angiogenesis. The gene discussed is VASH2; the disease is neoplasm.